Keytruda (pembrolizumab)

pCPA File Number: 20821
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Melanoma
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
pCODR 10058
pCPA Engagement Letter Issued:
Negotiation Process Concluded: